 |
|
|
|
|
| |
I not only ask my people to become Members, but also ask them to get involved with ISPE groups, like those working on the details of ISPE's technical guides and publications. Just being a Member is not good enough. You can only learn by getting involved.
Ulrich Rudow, V.P. Worldwide Engineering & Real Estate
Johnson & Johnson, USA
Watch the Video:
True Stories: What it means to be an ISPE Member - (WMV, 16 MB)
(Click to begin, or right-click to download and view later)
|
|
|
|
|
Pharmaceutical Engineering Archives |
July/August 2001
Volume 21, Number 4
Theme: Product Development
Table of Contents
Articles
An Interview with the Founders of Clark, Richardson & Biskup – ISPE Company of the Year
by Doyle Clark, Gerry Richardson & Jeff Biskup
The founders of CRB, Doyle Clark, Gerry Richardson, and Jeff Biskup, discuss the changes they have seen in the industry and challenges they see for the future.
Download Article...
|
The Use of Airflow Modelling in the Design of Pharmaceutical Containment Systems
by Andrew Ramsden
An exploration into the use of Computation Fluid Dynamics (CFD), during the design of containment solutions.
Download Article...
|
Barrier Isolation Technology: A Safe and Effective Solution for Providing Pharmaceutical Development Facilities
by Daniel Liberman, Christopher Lockwood, Mary McConnell-Meachen, Eugene J. McNally, Hank Rahe, Kevin Shepard & Glenn Snow
This article describes the use of barrier isolator technology to contain potent compounds during pharmaceutical dosage form development.
Download Article...
|
The Changing Face of Engineering for Major Capital Projects
by Joseph Hettenbach
This article explores how better relationships between customers and engineering design companies result in improved quality, better performance, and a cost-effective process.
Download Article...
|
Pharmaceutical Glossary: C-E
by Michelle M. Gonzalez
Part Two (C-E) of a glossary that can be viewed in its entirety on the ISPE Web site www.ispe.org.
Download Article...
|
|
Fast to Phase I Clinical Trials: A Comparison of In-House GMP Manufacturing and Clinical Trial Site Pharmacy Compounding
by Charles F. Carney & Eugene J. McNally, PhD
A comparison of compounding in the clinic and optimized GMP processes leads to the conclusion that each process has merits and is acceptable for Phase I supplies preparation and control.
Download Article...
|
|
|
|